When should prophylaxis therapy in inhibitor patients be considered?
G. YOUNG, G. AUERSWALD, V. JIMENEZ-YUSTE, B. A. KONKLE, T. LAMBERT, M. MORFINI, E. SANTAGOSTINO, V. BLANCHETTEVolume:
17
Year:
2011
Language:
english
Pages:
1
DOI:
10.1111/j.1365-2516.2011.02494.x
File:
PDF, 197 KB
english, 2011